Anika Therapeutics is a global joint preservation company. Co. is focused on orthopedics, including: Osteoarthritis Pain Management, which consists of Monovisc and Orthovisc, Cingal, and Hyvisc; Joint Preservation and Restoration, which include bone preserving joint technologies, soft tissue repair and regenerative solutions; and Non-Orthopedic, which consists of Hyalobarrier, an anti-adhesion barrier indicated for use after abdomino-pelvic surgeries, Hyalomatrix, which is used for the treatment of complex wounds such as burns and ulcers, as well as products used in connection with the treatment of ears, nose and throat disorders, and ophthalmic products. We show 58 historical shares outstanding datapoints in our ANIK shares outstanding history coverage, used to compute ANIK market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing ANIK market cap history over the course of time is important for investors
interested in comparing ANIK's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of ANIK versus a peer is one thing; comparing
ANIK market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like ANIK can fluctuate over the course of history.
With this page we aim to empower investors researching ANIK by allowing them to research the ANIK market cap history. |
Free ANIK Email Alerts:
Video: The Importance of Market Cap
